Assessment of Knowledge, Attitude, Practice, and Phobia Related to Corticosteroids and Drugs Containing Corticosteroids Among Pharmacists in Ambo Town
DOI:
https://doi.org/10.5530/ajphs.2026.16.93Keywords:
Corticosteroids, Knowledge, Attitudes, Practices, Phobia, PharmacistsAbstract
Background: Corticosteroid-containing medications are widely available in various forms, including topical applications, injections, and inhalers. Due to concerns about their safety, healthcare providers, particularly pharmacists, often approach the use and dispensing of these drugs with caution. Objective: This study was conducted to evaluate pharmacists' knowledge, attitudes, practices, and phobias regarding corticosteroids and corticosteroid-containing drugs in Ambo town. Methodology: A cross-sectional survey was conducted from April to June 2025, involving 62 pharmacists from public health facilities and community pharmacies in Ambo town. Data were collected using a structured questionnaire covering sociodemographic characteristics, knowledge, attitudes, practices, and phobias related to corticosteroids (CSs). Descriptive statistics were used to analyze the data. Results: The majority of pharmacists (93.5%) correctly identified CSs as anti-inflammatory agents, but only 43.5% recognized all major systemic side effects. Attitudes were generally positive, with 80.6% agreeing on the essential role of CSs; however, concerns about misuse (45.2% neutral) and overprescription (74.2% neutral) were noted. Counseling practices were inconsistent, with only 17.7% always providing advice. Phobia was prevalent, with 79% expressing concerns about long-term effects and more than 50% avoiding CS recommendations unless necessary. Conclusion: While pharmacists in Ambo town demonstrate foundational knowledge of CSs, significant gaps and high levels of phobia persist. Targeted education, standardized counseling protocols, and interprofessional collaboration are recommended to enhance pharmacists' confidence, improve patient counseling, and mitigate unwarranted fears, thereby ensuring the safe and effective use of corticosteroids.
References
Ahmad, D. S., Wazaify, M. M., & Albsoul-Younes, A. (2014). The role of the clinical pharmacist in the identification and management of corticophobia: An interventional study. Tropical Journal of Pharmaceutical Research, 13(3), 445–453. https://doi.org/10.4314/tjpr.v13i3.20
Barakat, M. M., Al-Qerem, W., & Jarab, A. S. (2023a). Assessment of knowledge, perception, experience and phobia toward corticosteroids use among the general public in the era of COVID-19: A multinational study. Healthcare, 11(2). https://doi.org/10.3390/healthcare11020255
Barakat, M. M., Al-Qerem, W., & Jarab, A. S. (2023b). Evaluation of knowledge, experiences, and fear toward prescribing and dispensing corticosteroids among Egyptian healthcare professionals: A cross-sectional study. Saudi Pharmaceutical Journal, 31(10). https://doi.org/10.1016/j.jsps.2023.101777
Barakat, M. M., Al-Qerem, W., & Jarab, A. S. (2024a). An evaluation of pharmacists' general attitudes, knowledge, and phobias regarding medications that include corticosteroids: A cross-sectional study. Journal of Pharmaceutical Health Care and Sciences, 10(1). https://doi.org/10.1186/s40780-024-00329-x
Barakat, M. M., Al-Qerem, W., & Jarab, A. S. (2024b). Healthcare providers' perspectives on corticosteroid-containing drugs: A cross-sectional study in the United Arab Emirates. Future Journal of Pharmaceutical Sciences, 10(1). https://doi.org/10.1186/s43094-024-00690-6
Barakat, M. M., Al-Qerem, W., & Jarab, A. S. (2024c). Understanding physicians' journeys with corticosteroids: Experiences, knowledge, and the shadows of fears. Preprints. https://doi.org/10.20944/preprints202407.2499.v1
Elalami, A., Talbi, M., Labaihi, A., & Abdallah, F.E.B. (2023). Misuse of corticosteroids in the Moroccan city of Laayoune. Moroccan Journal of Public Health, 5(1). https://doi.org/10.34874/PRSM.mjph-vol5iss1.38997
Giua, C., Floris, N.P., Schlich, M., Keber, E., & Gelmetti, C. (2021). Dermatitis in community pharmacies: a survey on Italian pharmacists' management and implications on corticophobia. Pharmacia, 68(3), 671-677. https://doi.org/10.3897/pharmacia.68.e70452
Grounds, K., Khan, I., Adlan, M., & Premawardhana, L. (2017). Poor knowledge of safety aspects of long-term steroid use among patients and healthcare professionals. Clinical Medicine, 17(4), 378. https://doi.org/10.7861/clinmedicine.17-4-378
Hudson, J.Q., Small, R.E., & Buckley, L. (1998). Perceptions of Pharmacists about Adverse Effects of Corticosteroid Therapy: Focus on Osteoporosis. Journal of the American Pharmaceutical Association (1996), 38(6), 710-716. https://doi.org/10.1016/s1086-5802(16)30392-8
Kang, M.J., Park, J.H., Park, S., Kim, N.G., Kim, E.Y., Yu, Y.M., Kim, D.Y., Lee, J.Y., Shin, W.G., & Choi, S.A. (2020). Community pharmacists' knowledge, perceptions, and practices about topical corticosteroid counseling: A real-world cross-sectional survey and focus group discussions in Korea. PLoS One, 15(7), e0236797. https://doi.org/10.1371/journal.pone.0236797
Koster, E.S., Philbert, D., Zheng, X., Moradi, N., de Vries, T.W., & Bouvy, M.L. (2021). Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis. International Journal of Clinical Pharmacy, 43(5), 1237-1244. https://doi.org/10.1007/s11096-021-01241-2
Lau, W. C., & Donyai, P. (2017). Knowledge, attitude and advice-giving behaviour of community pharmacists regarding topical corticosteroids. Pharmacy, 5(3), 41. https://doi.org/10.3390/pharmacy5030041
Mahdy, A., Hussain, N., Al Khalidi, D., & Said, A.S. (2017). Knowledge, attitude, and practice analysis of corticosteroid use among patients: A study based in the United Arab Emirates. National Journal of Physiology, Pharmacy and Pharmacology, 7(6), 562-568. https://doi.org/10.5455/njppp.2017.7.1234409022017
Nathan, A. D., Shankar, P. R., & Sreerramare, C. T. (2022). Community pharmacists' counseling practices and patient experiences about topical corticosteroids. https://doi.org/10.21203/rs.3.rs-1634168/v1
Said, A.S., Hussain, N., Abdelaty, L.N., Al Haddad, A.H., & Mellal, A.A. (2021). Inhaled corticosteroid phobia among parents of Egyptian asthmatic children. Clinical epidemiology and Global Health, 12, 100810. https://doi.org/10.1016/j.cegh.2021.100810
Samuel, S., Nguyen, T., & Choi, H. A. (2017). Pharmacologic characteristics of corticosteroids. Journal of Neurocritical Care, 10(2), 53-59. https://doi.org/10.18700/jnc.170035
Smith, S.D., Hong, E., Fearns, S., Blaszczynski, A., & Fischer, G. (2010). Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups. Australasian Journal of Dermatology, 51(3), 168-174. https://doi.org/10.1111/j.1440-0960.2010.00636.x
Smith, S.D., Harris, V., Lee, A., Blaszczynski, A., & Fischer, G. (2017). General practitioners' knowledge about use of topical corticosteroids in paediatric atopic dermatitis in Australia. Australian Family Physician, 46(5), 335-340. PMID: 28472581
Wondmkun, Y. T., & Ayele, A. G. (2021). Assessment of prescription pattern of systemic steroids in Addis Ababa. Patient Preference and Adherence, 15, 9–14. https://doi.org/10.2147/PPA.S285064
